Eduardo Salido

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Venues

Journal of personalized medicine

Journal of inherited metabolic disease

Genes

Journal of medicinal chemistry

Hospital Universitario de Canarias

Hospital Universitario de Canarias, Universidad La Laguna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario de Canarias

Spain

Professor and Chair :: Pathology

Education History

Hospital Universitario de Canarias, Universidad La Laguna

Spain

PHD :: Pathology

Publications

Eduardo Salido, David J Timson, Isabel Betancor-Fernández, Rogelio Jesús Palomino-Morales, Ernesto Anoz-Carbonell, Juan Luis Pacheco-Garcia, Milagros Medina, Angel L Pey
Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1. Journal of personalized medicine 12 (5) (2022)
Maria Dolores Moya-Garzon, Jose Antonio Gomez-Vidal, Alfonso Alejo-Armijo, Joaquı N Altarejos, Juan Roberto Rodriguez-Madoz, Miguel Xavier Fernandes, Eduardo Salido, Sofía Salido, Monica Diaz-Gavilan
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of personalized medicine 11 (2) (2021)
María Dolores Moya-Garzón, Cristina Martín Higueras, Pablo Peñalver, Manuela Romera, Miguel X Fernandes, Francisco Franco-Montalbán, Jose Antonio Gomez-Vidal, Eduardo Salido, Monica Diaz-Gavilan
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1. Journal of medicinal chemistry 61 (16) (2018)
Noel Mesa-Torres, Isabel Betancor-Fernández, Elisa Oppici, Barbara Cellini, Eduardo Salido, Angel L Pey
Evolutionary Divergent Suppressor Mutations in Conformational Diseases. Genes 9 (7) (2018)
Nerea Zabaleta, Miren Barberia, Cristina Martín Higueras, Natalia Zapata-Linares, Isabel Betancor, Saray Rodriguez, Rebeca Martinez-Turrillas, Laura Torella, Africa Vales, Cristina Olagüe, Amaia Vilas-Zornoza, Laura Castro-Labrador, David Lara-Astiaso, Felipe Prosper, Eduardo Salido, Gloria Gonzalez-Aseguinolaza, Juan Roberto Rodriguez-Madoz
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. Nature communications 9 (1) (2018)
Cristina Martin-Higueras, Armando Torres, Eduardo Salido
Molecular therapy of primary hyperoxaluria. Journal of inherited metabolic disease 40 (4) (2017)

Eduardo Salido.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eduardo Salido